205470 — Humasis Co Share Price
Last trade - 00:00- KR₩154bn
- -KR₩6bn
- KR₩25bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.69 | ||
| Price to Tang. Book | 0.71 | ||
| Price to Free Cashflow | 5.47 | ||
| Price to Sales | 6.24 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -18.29% | ||
| Return on Equity | -11.8% | ||
| Operating Margin | -180.47% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 45,717.21 | 321,829.14 | 471,272.76 | 13,827.3 | 25,413.32 | n/a | n/a | 22.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +587.2 | +29.15 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Humasis Co Ltd is a Korea-based company principally engaged in the manufacture and sale of in vitro diagnostic devices. The Company is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The Company sells its products within domestic market and to overseas markets. The Company was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.
Directors
- Jeong Hak Cha CEO (51)
- Hyeong Seon Kim OTH (40)
- Gwang Sik Cho DRC (54)
- Jeong Tae Kim DRC (46)
- Seok Jae Lee DRC (46)
- Yin Gyu Cho NID (54)
- Seong Cheol Yim NID (45)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 29th, 2014
- Public Since
- December 1st, 2014
- No. of Shareholders
- 63,122
- No. of Employees
- 241
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 113,153,840
- Address
- Hi Investment Bldg., ANYANG, 14042
- Web
- https://www.humasis.com/
- Phone
- +82 3180856200
- Auditors
- Sahmduk Accounting Corp.
Upcoming Events for 205470
Similar to 205470
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 21:10 UTC, shares in Humasis Co are trading at KR₩1,401. This share price information is delayed by 15 minutes.
Shares in Humasis Co last closed at KR₩1,401 and the price had moved by -20.81% over the past 365 days. In terms of relative price strength the Humasis Co share price has underperformed the FTSE Developed Asia Pacific Index by -19.91% over the past year.
There is no consensus recommendation for this security.
Find out moreHumasis Co does not currently pay a dividend.
Humasis Co does not currently pay a dividend.
Humasis Co does not currently pay a dividend.
To buy shares in Humasis Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩1,401, shares in Humasis Co had a market capitalisation of KR₩154bn.
Here are the trading details for Humasis Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 205470
Based on an overall assessment of its quality, value and momentum Humasis Co is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Humasis Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -1.43%.
As of the last closing price of KR₩1,401, shares in Humasis Co were trading -18.67% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Humasis Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,401.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Humasis Co's management team is headed by:
- Jeong Hak Cha - CEO
- Hyeong Seon Kim - OTH
- Gwang Sik Cho - DRC
- Jeong Tae Kim - DRC
- Seok Jae Lee - DRC
- Yin Gyu Cho - NID
- Seong Cheol Yim - NID